Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03333863
Other study ID # BASPP
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 25, 2017
Est. completion date October 31, 2019

Study information

Verified date May 2020
Source Shengjing Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Positive results of bacterial culture are analyzed comprehensively in Shengjing Hospital of China Medical University in recent 3 years(between 2015- 2017)


Recruitment information / eligibility

Status Completed
Enrollment 1889
Est. completion date October 31, 2019
Est. primary completion date June 30, 2018
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Clinical diagnosis of pneumonia, nephropyelitis, angiocholitis or other infectious diseases

- Positive results of bacterial cultures in blood, urine, sputum, and secretion

- The medical records of shengjing hospital of China Medical University from January 2015 to December 2017

Exclusion Criteria:

- Negative results of bacterial cultures in blood, urine, sputum, and secretion

Study Design


Related Conditions & MeSH terms


Intervention

Other:
descriptive study which reviewed the data of patients hospitalized with positive bacterial cultures
A retrospective, descriptive study was conducted at shengjing hospital of China Medical University between 2015- 2017. Data regarding bacterial culture isolates, antimicrobial susceptibility spectrum, and the general data of patients with fever or suspicion of sepsis were collected.

Locations

Country Name City State
China Shengjing hospital of China Medical University Shenyang Liaoning

Sponsors (1)

Lead Sponsor Collaborator
Shengjing Hospital

Country where clinical trial is conducted

China, 

References & Publications (1)

Musicha P, Cornick JE, Bar-Zeev N, French N, Masesa C, Denis B, Kennedy N, Mallewa J, Gordon MA, Msefula CL, Heyderman RS, Everett DB, Feasey NA. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998-2016): a surveillance study. Lancet Infect Dis. 2017 Oct;17(10):1042-1052. doi: 10.1016/S1473-3099(17)30394-8. Epub 2017 Aug 14. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary bacterial and antimicrobial susceptibility profile Primary outcome was recording the results of bacterial and antimicrobial susceptibility profile of pneumonia, nephropyelitis, or angiocholitis, measured with statistical methods. From January 2015 to December 2017
Secondary patient's critical condition Secondary outcome was evaluating the patient's critical condition, measured with APACHE (acute physiology and chronic health evaluation) II score. From January 2015 to December 2017